Central Venous Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Central Venous Catheters Pipeline Market Report Overview

A central venous catheter is a long, thin, flexible tube used to administer medicines, fluids, nutrients, or blood products and to monitor haemodynamic status of the patients in surgical and critical care settings over a long period of time, usually several weeks or more. These come in different sizes. Antimicrobial, non-antimicrobial, and peripherally inserted central venous catheters are included under this category.

The central venous catheters pipeline market research report provides comprehensive information about the central venous catheters pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments PICC (Peripherally Inserted Central Catheter) Lines and Antimicrobial Central Venous Catheters
Key Territories The US, Europe, China, India, and Japan
Key Regulatory Paths 510(k), CE, ICAC, Ninsho, and NMPA
Leading Companies Acatechol Inc, AngioDynamics Inc, Bactiguard Holding AB, CR Bard Inc, DAK Scientific Inc, Lipocoat BV, LiquiGlide Inc, Sharklet Technologies Inc, Terumo Corp, Velano Vascular East, and Vindica Therapeutics, Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Central Venous Catheters Pipeline Market Segments

The central venous catheters pipeline market segments are PICC (Peripherally Inserted Central Catheter) Lines and Antimicrobial Central Venous Catheters. In 2023, PICC (Peripherally Inserted Central Catheter) Lines segment holds the largest market share. A PICC line is a long, thin, soft, and flexible catheter (tube) that is inserted through a peripheral vein preferably in the upper arms and moves along until the tip of the tube reaches a large vein above the heart.

It comes in various sizes with single and multiple lumens. It can be used for administration of intravenous (IV) fluids or antibiotics, nutrition or medication, and chemotherapy. One unit refers to one PICC (Peripherally Inserted Central Catheter) Line.

Central Venous Catheters Pipeline Market Analysis by Segments, 2023 (%)

Central Venous Catheters Pipeline Market Analysis by Segments, 2023 (%)

For more segment-wise insights on the central venous catheters pipeline market, download a free sample report

Central Venous Catheters Pipeline Market Segmentation by Territories

Some of the territories in the central venous catheters market are the United States (US), Europe, China, India, and Japan among others. As of June 2023, the United States had the highest number of pipeline products.

Central Venous Catheters Pipeline Market Analysis, by Territories, 2023 (%)

Central Venous Catheters Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the central venous catheters pipeline market, download a free report sample

Central Venous Catheters Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the central venous catheters pipeline market are 510(k), CE, ICAC, Ninsho, and NMPA among others. As of June 2023, 510(k) was the most followed pathway for pipeline products.

Central Venous Catheters Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Central Venous Catheters Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the central venous catheters pipeline market, download a free report sample

Central venous catheters Pipeline Market – Competitive Landscape

Some of the key companies in the central venous catheters pipeline market are Acatechol Inc, AngioDynamics Inc, Bactiguard Holding AB, CR Bard Inc, Lipocoat BV, Sharklet Technologies Inc, Terumo Corp, Velano Vascular East, and Vindica Therapeutics, Inc among others.

Acatechol Inc: Acatechol Inc (Acatechol) a biotechnology research company which focuses R&D, treatment and other related services. The company is headquartered in Vista, California, the US.

Segments Covered in the Report

Central Venous Catheters Pipeline Market Territories Outlook

  • PICC (Peripherally Inserted Central Catheter) Lines
  • Antimicrobial Central Venous Catheters

Central Venous Catheters Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • India
  • Japan

Central Venous Catheters Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • ICAC
  • Ninsho
  • NMPA

Scope

  • Extensive coverage of the central venous catheters under development
  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of central venous catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with the potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of central venous catheters under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Acatechol Inc
Air Force Research Laboratory
AngioDynamics Inc
Ash Access Technology Inc
Bactiguard Holding AB
Charite University Hospital of Berlin
CR Bard Inc
DAK Scientific Inc
FreeFlow Medical Devices LLC
Globe Medical Tech Inc (Inactive)
Lipocoat BV
LiquiGlide Inc
Marvao Medical Devices Ltd
NHC LLC
Protectus Medical Devices, Inc.
S3V Vascular Technologies
Sharklet Technologies Inc
Silver Bullet Therapeutics, Inc.
Tel Aviv University
Terumo Corp
University of Illinois at Chicago
University of Texas Health Science Center at Houston
University of Washington
Velano Vascular East
Vindica Therapeutics, Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Central Venous Catheters Overview 8

3 Products under Development 9

3.1 Central Venous Catheters – Pipeline Products by Stage of Development 9

3.2 Central Venous Catheters – Pipeline Products by Segment 10

3.3 Central Venous Catheters – Pipeline Products by Territory 11

3.4 Central Venous Catheters – Pipeline Products by Regulatory Path 12

3.5 Central Venous Catheters – Pipeline Products by Estimated Approval Date 13

4 Central Venous Catheters – Pipeline Products under Development by Companies 14

4.1 Central Venous Catheters Companies – Pipeline Products by Stage of Development 14

4.2 Central Venous Catheters – Pipeline Products by Stage of Development 16

5 Central Venous Catheters Companies and Product Overview 17

5.1 Acatechol Inc Company Overview 17

5.1.1 Acatechol Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Air Force Research Laboratory Company Overview 18

5.2.1 Air Force Research Laboratory Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 AngioDynamics Inc Company Overview 19

5.3.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 Ash Access Technology Inc Company Overview 21

5.4.1 Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 Bactiguard Holding AB Company Overview 22

5.5.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 Charite University Hospital of Berlin Company Overview 23

5.6.1 Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 CR Bard Inc Company Overview 24

5.7.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 DAK Scientific Inc Company Overview 27

5.8.1 DAK Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.9 FreeFlow Medical Devices LLC Company Overview 28

5.9.1 FreeFlow Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 28

5.10 Globe Medical Tech Inc (Inactive) Company Overview 29

5.10.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29

5.11 Lipocoat BV Company Overview 30

5.11.1 Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview 30

5.12 LiquiGlide Inc Company Overview 31

5.12.1 LiquiGlide Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.13 Marvao Medical Devices Ltd Company Overview 32

5.13.1 Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.14 NHC LLC Company Overview 33

5.14.1 NHC LLC Pipeline Products & Ongoing Clinical Trials Overview 33

5.15 Protectus Medical Devices, Inc. Company Overview 34

5.15.1 Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

5.16 S3V Vascular Technologies Company Overview 35

5.16.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview 35

5.17 Sharklet Technologies Inc Company Overview 36

5.17.1 Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.18 Silver Bullet Therapeutics, Inc. Company Overview 37

5.18.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

5.19 Tel Aviv University Company Overview 38

5.19.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 38

5.20 Terumo Corp Company Overview 39

5.20.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 39

5.21 University of Illinois at Chicago Company Overview 40

5.21.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 40

5.22 University of Texas Health Science Center at Houston Company Overview 41

5.22.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 41

5.23 University of Washington Company Overview 42

5.23.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 42

5.24 Velano Vascular East Company Overview 43

5.24.1 Velano Vascular East Pipeline Products & Ongoing Clinical Trials Overview 43

5.25 Vindica Therapeutics, Inc Company Overview 45

5.25.1 Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview 45

6 Central Venous Catheters- Recent Developments 46

6.1 May 16, 2023: PAVmed provides business update and Q1 financial results 46

6.2 May 05, 2023: PAVmed to hold a business update conference call and webcast on May 17, 2023 47

6.3 May 04, 2023: Teleflex reports first quarter financial results and full year 2023 outlook 48

6.4 Apr 20, 2023: Teleflex announces first quarter 2023 earnings conference call information 49

6.5 Mar 14, 2023: PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2022 Financial Results 49

6.6 Feb 23, 2023: Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results 51

6.7 Feb 21, 2023: Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference 56

6.8 Feb 09, 2023: Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information 56

6.9 Jan 06, 2023: BD Announces Webcast of Annual Meeting of Shareholders 56

6.10 Dec 15, 2022: PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform 56

6.11 Dec 08, 2022: BD Releases 2022 Global Inclusion, Diversity and Equity Annual Report 57

6.12 Dec 08, 2022: T2 Biosystems highlights peer-reviewed article linking COVID-19 and sepsis and underscoring CDC call for adoption of early and accurate microbial diagnosis to guide targeted initial antimicrobial therapy 58

6.13 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer 59

6.14 Nov 15, 2022: PAVmed Provides Business Update and Third Quarter 2022 Financial Results 59

6.15 Nov 04, 2022: Poly Medicure Announces Unaudited Standalone & Consolidated Financial Results for the Quarter Ended 0n 30th Sep. 2022 61

6.16 Oct 27, 2022: Teleflex Reports Third Quarter Financial Results And Full Year Outlook 62

6.17 Oct 13, 2022: Teleflex Announces Third Quarter 2022 Earnings Conference Call Information 62

6.18 Sep 15, 2022: Lifecome Biochemistry Co. Announces resignation of the company’s directors 62

6.19 Aug 30, 2022: PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference 62

6.20 Aug 24, 2022: BD to Present at the Wells Fargo 2022 Healthcare Conference 63

6.21 Aug 16, 2022: Pavmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results 63

6.22 Aug 15, 2022: Retractable Technologies Announces Results for the Periods Ended June 30, 2022 66

6.23 Aug 04, 2022: Poly Medicure announces Financial results For The Quarter Ended 30Th June 2022 67

7 Appendix 69

7.1 Methodology 69

7.2 About GlobalData 72

7.3 Contact Us 72

7.4 Disclaimer 72

Table

Central Venous Catheters – Pipeline Products by Stage of Development 9

Central Venous Catheters – Pipeline Products by Segment 10

Central Venous Catheters – Pipeline Products by Territory 11

Central Venous Catheters – Pipeline Products by Regulatory Path 12

Central Venous Catheters – Pipeline Products by Estimated Approval Date 13

Central Venous Catheters Companies – Pipeline Products by Stage of Development 14

Central Venous Catheters – Pipeline Products by Stage of Development 16

Acatechol Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Antimicrobial Central Venous Catheter – Product Status 17

Antimicrobial Central Venous Catheter – Product Description 17

Air Force Research Laboratory Pipeline Products & Ongoing Clinical Trials Overview 18

Pulsing Frontline Trace Catheter – Product Status 18

Pulsing Frontline Trace Catheter – Product Description 18

AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 19

BioFlo PICC Line Extension – Product Status 19

BioFlo PICC Line Extension – Product Description 19

Next Generation BioFlo PICC – Product Status 20

Next Generation BioFlo PICC – Product Description 20

Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 21

BaxCath Impregnation System – Product Status 21

BaxCath Impregnation System – Product Description 21

Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview 22

Transvascular Injection Catheter – Product Status 22

Transvascular Injection Catheter – Product Description 22

Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview 23

Central Venous Permanent Catheter – Product Status 23

Central Venous Permanent Catheter – Product Description 23

CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Anti-Thrombotic PICC – Product Status 24

Anti-Thrombotic PICC – Product Description 24

Antimicrobial PICC – Product Status 25

Antimicrobial PICC – Product Description 25

COVERT PowerPICC – Product Status 25

COVERT PowerPICC – Product Description 26

DAK Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 27

PICC Line – Product Status 27

PICC Line – Product Description 27

FreeFlow Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 28

TLP-Coated PICC Catheter – Product Status 28

TLP-Coated PICC Catheter – Product Description 28

Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29

Safety IV Catheter – Product Status 29

Safety IV Catheter – Product Description 29

Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview 30

Coated CVC Catheter – Product Status 30

Coated CVC Catheter – Product Description 30

LiquiGlide Inc Pipeline Products & Ongoing Clinical Trials Overview 31

LIS-Coated PICC – Product Status 31

LIS-Coated PICC – Product Description 31

Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

NexSite 8Fr Single Lumen Central Venous Catheter – Product Status 32

NexSite 8Fr Single Lumen Central Venous Catheter – Product Description 32

NHC LLC Pipeline Products & Ongoing Clinical Trials Overview 33

Otricath – Product Status 33

Otricath – Product Description 33

Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

Safety IV Catheter – Product Status 34

Safety IV Catheter – Product Description 34

S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview 35

3V AGILE – Product Status 35

3V AGILE – Product Description 35

Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Sharklet Central Venous Catheter – Product Status 36

Sharklet Central Venous Catheter – Product Description 36

Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

Cathanic Venous Catheter – Product Status 37

Cathanic Venous Catheter – Product Description 37

Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 38

Short Peripheral Infusion Catheter – Product Status 38

Short Peripheral Infusion Catheter – Product Description 38

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 39

TERUMO Surshield-PUR Safety I.V. Catheter – Product Status 39

TERUMO Surshield-PUR Safety I.V. Catheter – Product Description 39

University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 40

Extendable Intravenous Catheter – Product Status 40

Extendable Intravenous Catheter – Product Description 40

University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 41

Automated Catheter Insertion System – Product Status 41

Automated Catheter Insertion System – Product Description 41

University of Washington Pipeline Products & Ongoing Clinical Trials Overview 42

Advanced Medical Catheter – Product Status 42

Advanced Medical Catheter – Product Description 42

Velano Vascular East Pipeline Products & Ongoing Clinical Trials Overview 43

China Midline Catheter – Product Status 43

China Midline Catheter – Product Description 43

Next Gen Central Catheter – Product Status 44

Next Gen Central Catheter – Product Description 44

Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Anti-Thrombotic And Anti-Infective Central Venous Catheter – Product Status 45

Anti-Thrombotic And Anti-Infective Central Venous Catheter – Product Description 45

Glossary 71

Figures

Central Venous Catheters – Pipeline Products by Stage of Development 9

Central Venous Catheters – Pipeline Products by Segment 10

Central Venous Catheters – Pipeline Products by Territory 11

Central Venous Catheters – Pipeline Products by Regulatory Path 12

Central Venous Catheters – Pipeline Products by Estimated Approval Date 13

Frequently asked questions

Central Venous Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Central Venous Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Central Venous Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Central Venous Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.